Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | IKK16 | 2.0 | uM | 3 | G-CSF | 15.0 | 76 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | G-CSF | 17.0 | 63 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | G-CSF | 18.0 | 73 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | G-CSF | 16.0 | 58 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | G-CSF | 19.0 | 71 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 15.5 | 72 | ||||
RA1869 | 3 | G-CSF | 17.5 | 48 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 14.5 | 70 | ||||
N2759 | 3 | G-CSF | 14.0 | 47 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 15.0 | 52 | ||||
RA1931 | 3 | G-CSF | 14.0 | 74 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 18.0 | 65 | ||||
N2586 | 3 | G-CSF | 17.0 | 66 | |||||||
RA1869 | 3 | G-CSF | 18.0 | 52 | |||||||
N2759 | 3 | G-CSF | 16.0 | 61 | |||||||
RA1931 | 3 | G-CSF | 16.5 | 66 | |||||||
N2586 | 3 | G-CSF | 17.0 | 81 | |||||||
RA1869 | JNK-IN-8 | 3.0 | uM | 3 | G-CSF | 17.0 | 49 | ||||
RA1869 | PH-797804 | 0.6 | uM | 3 | G-CSF | 20.0 | 61 | ||||
N2759 | JNK-IN-8 | 3.0 | uM | 3 | G-CSF | 16.0 | 83 | ||||
N2759 | PH-797804 | 0.6 | uM | 3 | G-CSF | 16.0 | 66 | ||||
RA1931 | JNK-IN-8 | 3.0 | uM | 3 | G-CSF | 13.0 | 64 | ||||
RA1931 | PH-797804 | 0.6 | uM | 3 | G-CSF | 16.0 | 50 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | G-CSF | 16.0 | 58 | ||||
N2586 | PH-797804 | 0.6 | uM | 3 | G-CSF | 20.5 | 44 |